Can IVF in Georgia Select Gender? Legal and Medical Reality Explained

Direct Answer: Can IVF in Georgia Select Gender?

As a reproductive endocrinologist practicing in Georgia for many years, I give a direct clinical answer: Georgian law strictly prohibits embryo gender selection for non-medical reasons. Only when there is a clear medical indication—meaning one partner carries an X-linked genetic disease (such as hemophilia, Duchenne muscular dystrophy, fragile X syndrome, etc.)—is it permitted to select embryos of a specific sex for transfer through preimplantation genetic testing (PGT) to prevent disease inheritance.

In other words, if the sole reason is a preference for "wanting a boy" or "wanting a girl," this cannot be achieved at a legitimate fertility center in Georgia. Any institution claiming they can bypass the law to help with gender selection involves illegal operations, and patients must be highly vigilant.

Doctor's Perspective: Why Georgia Prohibits Non-Medical Sex Selection

From a medical ethics and legal standpoint, Georgia's "Assisted Reproductive Law" explicitly limits embryo gender selection to the prevention of serious genetic diseases. Reasons include:

• Risk of gender imbalance: Non-medical sex selection could lead to societal gender ratio imbalance; Georgia follows international assisted reproductive ethics consensus.
• Embryo discrimination issue: Discarding embryos based on gender rather than health reasons violates the principle of respect for embryos as potential life.
• Medical necessity priority: PGT technology itself carries a risk of embryo biopsy (approximately 1-2% embryo damage rate) and should only be used when necessary.

During consultations, I often encounter patients presenting materials from domestic agencies promoting "Georgia allows gender selection." In reality, only if a patient can provide a genetic counseling report from a tertiary hospital proving the risk of an X-linked disease will we initiate the PGT process and inform the laboratory of the required gender. Otherwise, only routine PGT-A (chromosomal aneuploidy screening) is performed, and embryo gender is not reported.

Differences Between Countries: Georgia Compared to Other Regions

Georgia's legal strictness is moderate, consistent with most European countries. Patients must distinguish between "medically permitted" and "personal preference."

Easiest Detail to Overlook: What Are the Specific Criteria for "Medical Indication"?

Many patients assume that a family history of genetic disease is sufficient, but actual implementation has clear requirements:

• Must identify the causative gene: Genetic testing must confirm that one partner carries a specific pathogenic mutation, and the disease must be clearly X-linked or Y-linked.
• Genetic counseling report: A report from a qualified genetic counselor or geneticist must state that gender selection is the only or best option to prevent the disease.
• Disease severity: Typically only for lethal or severely disabling diseases (e.g., Duchenne muscular dystrophy, hemophilia A/B, Hunter syndrome). Minor conditions (like red-green color blindness) are generally not considered medical indications.

Ignoring this, patients may spend significant time preparing for PGT only to be rejected by the fertility center. It is advisable to submit family genetic information to the target center for pre-screening before traveling to Georgia.

Easiest Pitfall: Agency Claims of "Guaranteed Gender Selection"

In ten years of practice, I have seen many cases where patients were misled by agencies:

1. Fabricated legal loopholes: Claiming "special procedures or connections" to select gender, which is actually illegal. If discovered by health authorities, embryos may be seized, and patients face legal risks.
2. Using low-price bait: Charging high additional fees under the guise of "gender selection," but the transferred embryos have not actually undergone PGT for gender identification; gender is guessed based on blastocyst morphology (very high false positive rate).
3. Blurring PGT and PGS concepts: Advertising "third-generation IVF" as being able to see gender, but standard PGT-A (aneuploidy screening) in Georgia does not report gender; only PGT-M (monogenic disease) clearly identifies embryo gender.

How to judge: Request written documentation from the center explicitly stating whether they offer non-medical gender selection and citing the legal basis. If they evade or are vague, it is essentially a sign of irregular practice.

Actual Process: How It Works When There Is a Medical Indication

If a couple meets the medical indication, the process for gender selection in Georgia is as follows:

• Step 1: Genetic confirmation in home country: Complete whole exome sequencing or targeted gene testing for both partners at a tertiary hospital, obtain a clear mutation report, and get a written opinion from a genetic counseling clinic recommending "embryo gender selection."
• Step 2: Choose a Georgian fertility center: Send the report to the center's medical department in advance for review to confirm they can accept such cases. Some centers require stricter ethics committee approval.
• Step 3: Undergo standard IVF + PGT: Ovarian stimulation, egg retrieval, in vitro fertilization, culture to blastocyst stage (day 5-6), biopsy 5-10 trophectoderm cells for PGT (M or SR).
• Step 4: Wait for test results: After about 2-3 weeks, obtain the embryo genetic report, which clearly indicates each embryo's gender and whether it carries the pathogenic gene.
• Step 5: Transfer the target gender healthy embryo: The doctor, based on the patient's wishes and ethical regulations, transfers the selected embryo that is free of the pathogenic gene and of the desired gender.

What to prepare: ID documents for both partners, marriage certificate, genetic disease diagnosis certificate, genetic counseling report, and previous reproductive history records.

How long it takes: From genetic preparation in the home country to the end of transfer, it usually takes 4-6 months (including 1-2 months of preparation, 2-3 months for ovarian stimulation and PGT testing, and 1 month for transfer and pregnancy test).

Frequently Asked Questions

Q: Doctor, I heard some small clinics in Georgia can privately select gender. Is that reliable?

A: Not reliable. The Georgian National Reproductive Medicine Supervision Agency conducts regular inspections. If small clinics are found violating rules, they risk license revocation. Moreover, private operations cannot guarantee laboratory quality, with high risks of embryo contamination and gender misdiagnosis. In case of disputes, patients have no legal protection.

Q: If my spouse and I have no genetic diseases but really want a girl, are there other legal ways?

A: Not in Georgia. You could consider some US states (e.g., California, Florida) or Northern Cyprus (some centers legally offer non-medical sex selection). However, you must research local laws and medical qualifications yourself.

Q: Will PGT-A automatically tell me the embryo's gender?

A: In standard Georgian laboratories (such as IVF Georgia, Beta Clinic), PGT-A reports only focus on numerical abnormalities of the 23 chromosome pairs and do not display specific results for sex chromosomes (X/Y) by default, unless the patient has a medical indication and has applied in advance. Some centers may even blur sex chromosome information in the report.

Q: Is third-generation IVF (PGT) expensive? Is it worth it for gender selection?

A: The cost of standard PGT-M in Georgia is about $8,000-$12,000 USD (including embryo testing fees, charged per embryo). If solely for gender selection, this cost is much higher than going directly to a country where it is legal, and it carries both ethical and legal risks, making it highly uneconomical.

Practitioner Observation: Why Patients Often Think Georgia Allows Gender Selection

I believe there are three main reasons:

• Historical misunderstanding: Before 2015, Georgian law did not explicitly prohibit gender selection, and some centers offered it. However, the revised Assisted Reproductive Law in 2018 completely banned non-medical gender selection, yet old information still circulates online.
• Agency rhetoric: To attract clients, agencies equate "third-generation IVF" with "can select gender," misleading patients into thinking Georgia is a permissive region.
• Comparison with Ukraine: Ukraine also prohibits non-medical sex selection, but some underground operations exist. Georgia is relatively strict, and legitimate institutions would never dare to violate the rules.

As a doctor in the field, I advise patients to seek treatment honestly and not attempt to deceive the center with false disease certificates (DNA testing will reveal the truth). If there is a genuine medical need, cooperate with the standard process; if it is purely personal preference, choose a country where such operations are legal to avoid violating local laws.

Risk Warning

Regardless of the reason for considering gender selection, please keep the following risks in mind:

• Legal risk: Providing false medical indications or participating in non-medical gender selection in Georgia may result in being blacklisted for assisted reproduction or even facing deportation.
• Embryo loss risk: PGT biopsy may damage approximately 1-2% of usable embryos; if the number of embryos of the target gender is insufficient, multiple egg retrievals may be needed, increasing physical burden.
• Psychological risk: Fixation on a specific gender can increase anxiety, and if transfer fails or the desired outcome is not achieved, it may lead to parent-child relationship difficulties. Studies show that non-medical gender selection does not improve family satisfaction.
• Financial risk: Irregular institutions have chaotic fee structures, may demand extra "facilitation fees" or high agency fees, ultimately leaving patients with nothing.

If you are undergoing IVF in Georgia, be sure to choose a fertility center holding a formal license issued by the Georgian National Reproductive Medicine Supervision Agency, and carefully read the ethical clauses in the treatment contract.